Karen Gelmon
- Oncology top 1%
- Cancer Research top 0.5%
- Genetics top 2%
- Pathology and Forensic Medicine top 1%
- Pulmonary and Respiratory Medicine top 5%
- Co-authors
- Torsten O. NielsenMaggie C.U. CheangScott TyldesleyK. David VoducHagen F. KenneckeSharon H. GiordanoHolly AndersonClifford A. Hudis
- Topics
- Breast Cancer Treatment Studies (11 papers)HER2/EGFR in Cancer Research (10 papers)Cancer Treatment and Pharmacology (6 papers)
- Partner nations
- CanadaUnited StatesJapan
In The Last Decade
Karen Gelmon
29 papers receiving 4.0k citations
Hit Papers
Peers
Comparison fields: 5 of 111
- Oncology 2.1k
- Cancer Research 1.9k
- Genetics 1.0k
- Pathology and Forensic Medicine 813
- Pulmonary and Respiratory Medicine 705
Countries citing papers authored by Karen Gelmon
This map shows the geographic impact of Karen Gelmon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karen Gelmon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karen Gelmon more than expected).
Fields of papers citing papers by Karen Gelmon
This network shows the impact of papers produced by Karen Gelmon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karen Gelmon. The network helps show where Karen Gelmon may publish in the future.
Co-authorship network of co-authors of Karen Gelmon
This figure shows the co-authorship network connecting the top 25 collaborators of Karen Gelmon. A scholar is included among the top collaborators of Karen Gelmon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karen Gelmon. Karen Gelmon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 3 | |
| 2 | 210 | |
| 3 | 19 | |
| 4 | 16 | |
| 5 | 303 | |
| 6 | Abstract #3603: ARRY-334543 in ErbB2 positive metastatic breast cancer and other ErbB expressing-cancers: experience from expansion cohorts on a phase I study | 2 |
| 7 | 112 | |
| 8 | 2 | |
| 9 | 88 | |
| 10 | Locoregional Radiation Therapy in Patients With High-Risk Breast Cancer Receiving Adjuvant Chemotherapy: 20-Year Results of the British Columbia Randomized Trialbreakdown → | 757 |
| 11 | 3 | |
| 12 | 16 | |
| 13 | 75 | |
| 14 | 61 | |
| 15 | 7 | |
| 16 | 3 | |
| 17 | 17 | |
| 18 | 17 | |
| 19 | Quality of life, appetite, and weight change in patients receiving dose-intensive chemotherapy. | 35 |
| 20 | 1 |
About Karen Gelmon
Karen Gelmon is a scholar working on Cancer Research, Oncology and Pulmonary and Respiratory Medicine, having authored 29 papers that have together received 4.2k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (11 papers), HER2/EGFR in Cancer Research (10 papers) and Cancer Treatment and Pharmacology (6 papers). The work is most often cited by research in Cancer Research (1.9k citations), Oncology (2.1k citations) and Family Practice (115 citations). Karen Gelmon has collaborated with scholars based in Canada, United States and Japan. Frequent co-authors include Torsten O. Nielsen, Maggie C.U. Cheang, Scott Tyldesley, K. David Voduc, Hagen F. Kennecke, Sharon H. Giordano, Holly Anderson, Clifford A. Hudis, Jennifer J. Griggs and Vered Stearns. Their work appears in journals such as The Lancet, Journal of Clinical Oncology and JNCI Journal of the National Cancer Institute.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.